Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide in Chronic Charcot Neuroarthropathy
NCT02023411Phase 2Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jan 2014
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Charcot neuroarthropathy (CN) comparing Teriparatide with Placebo (2 arms). Primary endpoint: Standardized Uptake Value Maximum on PET/CT Scan at 12 months. Started Jan 2014; status: completed.
02
Drugs
teriparatide
03
Conditions
Charcot neuroarthropathy (CN)
Beyond the preview
Go deeper on NCT02023411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02023411.